A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Shanghai Jiao Tong University School of Medicine
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Prescient Therapeutics, Ltd.
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
SciTech Development, Inc.
City of Hope Medical Center
Mayo Clinic
Icahn School of Medicine at Mount Sinai
Barbara Ann Karmanos Cancer Institute
Stanford University
City of Hope Medical Center
Thomas Jefferson University
Washington University School of Medicine